Predicting 6-week treatment response to escitalopram pharmacotherapy in late-life major depressive disorder. - Wikidata - wikimedia - TriplyDB

Predicting 6-week treatment response to escitalopram pharmacotherapy in late-life major depressive disorder.

Predicting 6-week treatment response to escitalopram pharmacotherapy in late-life major depressive disorder.

http://www.wikidata.org/entity/Q36630401

about

Why do some promising brain-stimulation devices fail the next steps of clinical development?Early prediction of acute antidepressant treatment response and remission in pediatric major depressive disorder.Rescue pharmacotherapy with duloxetine for selective serotonin reuptake inhibitor nonresponders in late-life depression: outcome and tolerability.Use of the late-life function and disability instrument to assess disability in major depression.Analysing psychosocial difficulties in depression: a content comparison between systematic literature review and patient perspective The MMSE is not an adequate screening cognitive instrument in studies of late-life depression.Anxiety impairs depression remission in partial responders during extended treatment in late-life Perceived social support mediates anxiety and depressive symptom changes following primary care intervention Incomplete response in late-life depression: getting to remission Patient preferences for treatment of major depressive disorder and the impact on health outcomes: a systematic review.White Matter Hyperintensity Accumulation During Treatment of Late-Life Depression.A Meta-Analysis of Executive Dysfunction and Antidepressant Treatment Response in Late-Life Depression.Impact of close family members on older adults' early response to depression treatment.Executive dysfunction and treatment response in late-life depression.Comprehensive review of factors implicated in the heterogeneity of response in depression.Treatment outcome in psychiatric inpatients: the discriminative value of self-esteem.Predictive socioeconomic and clinical profiles of antidepressant response and remission.Estimating probability of sustained recovery from mild to moderate depression in primary care: evidence from the THREAD study.Role of the serotonin transporter gene locus in the response to SSRI treatment of major depressive disorder in late life.Relationship of endothelial function and atherosclerosis to treatment response in late-life depression.

P2860

Q33519672-9230D3BB-38BA-4779-ACE9-602E317830C1 Q33655082-94353498-0C62-4704-9788-15BEFA8D1FF4 Q33755508-2A704A7E-B569-4C45-9F9E-25E52AA4B216 Q33786939-878A719B-DB79-42AB-921A-4AF91682AF20 Q33804038-C8BA623D-EC85-4154-B42A-2C013CBD494F Q33857699-F1C9F6F6-6392-4799-9B09-AB2236B35089 Q34032416-7080E136-85F2-4FEA-9B5A-E27BA2DC66AB Q34060355-8550C24E-50B0-4089-A1A7-2C63E1485951 Q35237063-98677B00-7C56-4150-99E6-C74220C33787 Q35702981-860E40BF-78DD-41E4-A7FA-BD2F83E7F861 Q36894502-944E05D7-BABB-468F-AE6F-B5CDC3531094 Q37054983-9F1F0F2D-E521-4D89-9502-DD805B9FCD8B Q37458254-437A6F9F-0E69-41DD-90CC-C29206C5D330 Q37947201-F782E3A3-6BD1-4BC3-A481-745B6845CC0B Q38003344-70A8F6A1-671D-46D6-99AD-9A64D4FB61E3 Q39921700-A73E93D6-CFDF-404C-B182-0D61725E78CD Q44209591-78C45E52-C6EB-4BAF-9E2A-8157BEAC0F60 Q46495664-8C9F5768-B65A-4D4A-9F16-2DE2212FAE99 Q48086902-91F7728F-3501-4DC2-BBB4-399AB89CA75F Q48763940-C3806684-62BA-412D-8068-F549734B3547

P2860

Predicting 6-week treatment response to escitalopram pharmacotherapy in late-life major depressive disorder.

http://www.wikidata.org/entity/Q36630401

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Predicting 6-week treatment re ...... ife major depressive disorder.

@ast

Predicting 6-week treatment re ...... ife major depressive disorder.

@en

type

label

Predicting 6-week treatment re ...... ife major depressive disorder.

@ast

Predicting 6-week treatment re ...... ife major depressive disorder.

@en

prefLabel

Predicting 6-week treatment re ...... ife major depressive disorder.

@ast

Predicting 6-week treatment re ...... ife major depressive disorder.

@en

P1433

Q36630401-1039C3F6-2450-4BBF-9484-295AC6769208

P1476

Q36630401-E7827079-5603-46BC-A1BC-E05D3928F963

P2093

Q36630401-05285E2C-8550-44BB-92EC-58ABC6B4B2FF

Q36630401-19E6DA17-12FF-477C-8E0C-C7D885BB88B3

Q36630401-24590A55-059F-4FEE-8365-440B9FF1F57A

Q36630401-3817EF34-2C42-4CF9-8E35-52DADC8FBB35

Q36630401-4DF449EB-6E3E-46AC-9DD2-122E3B6297DC

Q36630401-52549494-0E24-4361-897D-289FD9E77EEE

Q36630401-58D5AA2D-275E-43DD-A46C-61EC4D6D3467

Q36630401-5F264092-1397-44B5-A1BD-FF2904D1887C

Q36630401-705E28AC-D0C8-41CD-9449-FED39DE52B50

Q36630401-7BD5A862-094F-46ED-8176-1580B8778722

P2860

Q36630401-12D1A68D-F0AD-4F48-8C3A-12E1FAE9DA4D

Q36630401-1CEF8411-0F30-4D2D-B63C-51E668406A5A

Q36630401-25667392-EECD-4A40-995B-21F67015707E

Q36630401-25CC5F75-FDA7-4AB5-B068-C5A5C437860E

Q36630401-2FAB3CA2-0BE9-49B2-A658-52CC499C3379

Q36630401-30B23D9F-288B-4F4A-8004-D21545FBF0BB

Q36630401-336409D1-8704-4819-8C54-ECDF20F0AAF6

Q36630401-34E3DC30-A521-458C-85D3-D7D4BECC5AF7

Q36630401-37DE4C75-05DB-4304-AAF3-706E594892E5

Q36630401-39C80EBE-03D1-42C4-ABFC-A6389F86DBAA

P304

Q36630401-9A1B49D0-9FCF-4623-9580-A6B8ACE93A24

P31

Q36630401-089BD73C-C2BE-47FE-9F86-7BEFDD9E5963

P356

Q36630401-A1B6EABF-B06E-4990-B6FB-2C1F747CBC2B

P407

Q36630401-72F754E9-8F79-448F-ADD4-1EF4BC175804

P433

Q36630401-0793BD18-A8FC-4A8C-9C80-DDBF19F5110B

P478

Q36630401-F5FE90B8-8584-4A19-B1C3-08879453CCF7

P50

Q36630401-B284AF1E-8C3A-4AFE-8EF9-4B5C672AE846

P577

Q36630401-468CCA52-988E-4ECC-A3B8-38E4A26B763A

P698

Q36630401-716B4896-A460-4E3B-A7C9-99F6BFA0BC22

P921

Q36630401-746AC198-6778-41A8-BE63-2F6AD8D195EF

P932

Q36630401-803E922F-3155-4530-872B-0C90D90C69B4

P356

P1433

International Journal of Geriatric Psychiatry

P1476

Predicting 6-week treatment re ...... ife major depressive disorder.

@en

P2093

Ariel Gildengers

http://www.w3.org/2001/XMLSchema#string

Benoit H Mulsant

http://www.w3.org/2001/XMLSchema#string

Charlotte Brown

http://www.w3.org/2001/XMLSchema#string

Elizabeth Weber

http://www.w3.org/2001/XMLSchema#string

Ellen Frank

http://www.w3.org/2001/XMLSchema#string

Ellen Whyte

http://www.w3.org/2001/XMLSchema#string

Eric J Lenze

http://www.w3.org/2001/XMLSchema#string

Francis Lotrich

http://www.w3.org/2001/XMLSchema#string

Jacqueline Stack

http://www.w3.org/2001/XMLSchema#string

Jennifer Morse

http://www.w3.org/2001/XMLSchema#string

P2860

“Mini-mental state”

The MOS 36-ltem Short-Form Health Survey (SF-36)

The assessment of anxiety states by rating

Development of a rating scale for primary depressive illness

Remission in depressed geriatric primary care patients: a report from the PROSPECT study.

Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale.

Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.

Polymorphism of the serotonin transporter: implications for the use of selective serotonin reuptake inhibitors.

Anxiety symptoms in elderly patients with depression: what is the best approach to treatment?

Time course of response to antidepressants in late-life major depression: therapeutic implications.

P304

1141-1146

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/GPS.1804

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

Charles F Reynolds

P577

2007-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17486678

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy

P932

3579589

http://www.w3.org/2001/XMLSchema#string